Research Article
Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma
Figure 6
Prognostic value of the risk signature in hepatocellular carcinoma patients classified into specific cohorts. The Kaplan–Meier survival curve for patients with (a) , (b) , (c) female, (d) male, (e) grade 1-grade 2, (f) grade 3-grade 4, (g) stages I-II, (h) stages III-IV.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |